Role of interferon alfa-2b in the induction and maintenance treatment of low-grade non-Hodgkin's lymphoma: results from a prospective, multicenter trial with double randomization.R. Arranz, J M Fernández-Rañada, Pilar García‐Alfonso et al.|Journal of Clinical Oncology|1998Cited by 56
Networking for advanced molecular diagnosis in acute myeloid leukemia patients is possible: the PETHEMA NGS-AML projectClaudia Sargas, Pau Montesinos, Rosa Ayala et al.|Haematologica|2020Cited by 37
Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA RegistryClaudia Sargas, Rosa Ayala, María José Larráyoz et al.|Cancers|2023Cited by 30
Clinical characteristics of patients with central nervous system relapse in BCR-ABL1-positive acute lymphoblastic leukemia: the importance of characterizing ABL1 mutations in cerebrospinal fluidRicardo Sánchez, Joaquín Martínez‐López, Rosa Ayala et al.|Annals of Hematology|2017Cited by 30
Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA groupClaudia Sargas, Rosa Ayala, María José Larráyoz et al.|Blood Cancer Journal|2023Cited by 28